Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aquaflo sheet 3.8cm discs
20031200035
|
Aquaflo sheet 3.8cm discs | Wound Management & Other Dressings | Dressings | No data available |
|
Aquaflush 200 standard set
21280000186
|
Aquaflush 200 standard set | Anal Irrigation System | Appliances | No data available |
|
Aquaflush 200X standard set
21280000189
|
Aquaflush 200X standard set | Anal Irrigation System | Appliances | No data available |
|
Aquaflush 500X short cone set
21280000187
|
Aquaflush 500X short cone set | Anal Irrigation System | Appliances | No data available |
|
Aquaflush 500X SRC set
21280000190
|
Aquaflush 500X SRC set | Anal Irrigation System | Appliances | No data available |
|
Aquaflush 500X standard set
21280000188
|
Aquaflush 500X standard set | Anal Irrigation System | Appliances | No data available |
|
Aquaflush anal irrigation system straps
21280000125
|
Aquaflush anal irrigation system straps | Anal Irrigation System | Appliances | No data available |
|
Aquaflush Quick System starter set
21280000122
|
Aquaflush Quick System starter set | Anal Irrigation System | Appliances | No data available |
|
AquaForm Hydrogel dressing
20030500060
|
AquaForm Hydrogel dressing | Wound Management & Other Dressings | Dressings | No data available |
|
AquaLube PF 0.5% eye drops preservative free
21300000996
|
AquaLube PF 0.5% eye drops preservative free | Eye Products | Appliances | No data available |
|
Aquamol cream
21220000106
|
Aquamol cream | Emollients | Appliances | No data available |
|
Aquasept 2% skin cleanser
1311050U0BFAAAD
|
Aquasept | Triclosan | Skin | No data available |
|
Aquasol A Parenteral 100,000units/2ml inj vials
0906011D0BFACAW
|
Aquasol A | Vitamin A | Nutrition and Blood | No data available |
|
Aqumeldi 1mg orodispersible tablets
0205051I0BFABCE
|
Aqumeldi | Enalapril maleate | Cardiovascular System | No data available |
|
Aragam 10g/200ml solution for infusion vials
1405010A0CCACAC
|
Aragam | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Aragam 2.5g/50ml solution for infusion vials
1405010A0CCAAAL
|
Aragam | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Aragam 20g/400ml solution for infusion vials
1405010A0CCADBT
|
Aragam | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Aragam 5g/100ml solution for infusion vials
1405010A0CCABAN
|
Aragam | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Aramine 10mg/1ml solution for injection ampoules
0207020L0BBAAAB
|
Aramine | Metaraminol | Cardiovascular System | No data available |
|
Aranesp 15micrograms/0.375ml inj pre-filled syringes
0901030J0BBADAD
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp 300micrograms/0.6ml inj pre-filled syringes
0901030J0BBAKAK
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 100micrograms/0.5ml inj pre-filled pens
0901030J0BBASAS
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 130micrograms/0.65ml inj pre-filled pens
0901030J0BBAWAW
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 150micrograms/0.3ml inj pre-filled pens
0901030J0BBATAT
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 300micrograms/0.6ml inj pre-filled pens
0901030J0BBAUAU
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.